Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4583 Monkeypox Concept

Closed 03-18 16:00:00 EDT

1,932.18

-39.13

-1.98%

High1,971.28	Low1,911.50	Vol19.54M
Open1,971.28	D1 Closing1,971.31	Amplitude3.03%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O1.28B	T/O Rate--	Tradable Shares0.00
P/B4.799297	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":1932.1808,"timestamp":1773863999999,"preClose":1971.3064,"halted":0,"volume":19543024,"delay":0,"changeRate":-0.019848,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-39.12561,"latestTime":"03-18 16:00:00 EDT","open":1971.2822,"high":1971.2822,"low":1911.4996,"amount":1275294131.52849,"amplitude":0.030326,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1773878400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.799297,"peRate":37.649978,"turnoverRate":0.007286,"increases":1,"decrements":9,"flats":0,"marketCap":213670855734.625,"floatMarketCap":213155756523.5},"requestUrl":"/m/hq/s/BK4583/tweets","defaultTab":"tweets","newsList":[{"id":"2620267393","title":"Gilead Sciences Inc. Stock Underperforms Wednesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2620267393","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620267393?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:35","pubTimestamp":1773866100,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  shed 2.15% to $141.29 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 1.36% to 6,624.70 and Dow Jones Industrial Average  falling 1.63% to 46,225.15.This was the stock's second consecutive day of losses.Gilead Sciences Inc. closed 10.17% short of its 52-week high of $157.29, which the company reached on February 11th.The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 0.35% to $237.28, Pfizer Inc.  fell 0.47% to $27.32, and Abbott Laboratories  fell 2.01% to $108.49.Trading volume  remained 564,103 below its 50-day average volume of 7.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 18, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550577.SGD","LU0345769631.USD","LU1037948897.HKD","LU1732799900.SGD","GILD","LU2468319806.SGD","IE0034235303.USD","LU1732800096.USD","LU1244550221.USD","LU0225771236.USD","LU1934455277.USD","BK4592","BK4139","IE0002270589.USD","LU1691799644.USD","LU1496350502.SGD","LU1066051225.USD","SG9999001176.SGD","SGXZ23171101.USD","LU0985481810.HKD","LU0114720955.EUR","BK4532","LU1280957306.USD","LU1162221912.USD","LU2471134523.USD","SG9999002224.SGD","LU1221951046.USD","IE00B3PB1722.GBP","IE00BJT1NW94.SGD","LU2112291526.USD","BK4007","LU0306807586.USD","BK4504","IE00BVYPNW00.USD","LU1196500208.SGD","BK4082","IE00B42XCP33.USD","IE00B4R5TH58.HKD","LU1983299246.USD","LU2430703178.SGD","LU0795875169.SGD","LU2430703095.HKD","LU0965509010.AUD","LU0306806265.USD","LU0289739699.SGD","LU1066051811.HKD","BK4588","IE00BFXG1179.USD","LU1506573853.SGD","LU1894683348.USD","LU0640476718.USD","BK4581","BK4583","LU0124676726.USD","LU0889565916.HKD","LU0170899867.USD","BK4566","LU1585245621.USD","LU1934455194.USD","LU0321505868.SGD","LU2237957902.USD","LU1032466523.USD","SG9999013999.USD","IE00BGHQF631.EUR","IE00B19Z3B42.SGD","IE00BJJMRZ35.SGD","LU0321505439.SGD","LU2324357040.USD","LU1778281490.HKD","BK4550","SG9999001176.USD","LU0912757837.SGD","LU1571399168.USD","LU1935042991.SGD","IE00BLSP4452.SGD","LU0792757196.USD","BK4585","SG9999003800.SGD","LU0456855351.SGD","LU2430703251.USD","IE00B1BXHZ80.USD","LU0985320562.USD","LU1721429402.USD","SG9999001440.SGD","LU1674673691.USD","LU2592432038.USD","IE00B2B36J28.USD","IE00BSNM7G36.USD","LU0466842654.USD","LU1989763427.SGD","IE00BKVL7J92.USD","LU0058720904.USD","IE0001KFT4U8.USD","IE00BDGV0183.EUR","LU1037948541.HKD","IE000M9KFDE8.USD","IE00BVYPNV92.GBP","LU1244550494.USD","LU2750360997.AUD","LU0203345920.USD","LU1934455863.HKD","LU2129689431.USD","LU2089984988.USD","LU1059921491.USD","LU2133065610.SGD","LU2211815571.USD","LU1261432733.SGD","SG9999011175.SGD","LU0109394709.USD","BK4568","LU0965508806.USD","BK4559","LU0320765646.SGD","LU1066053197.SGD","SG9999015978.USD","LU1929549753.HKD","BK4578","LU1267930813.SGD","LU2505996509.AUD","IE00B7SZLL34.SGD","LU1023059063.AUD","SG9999002232.USD","SG9999004303.SGD","IE00BFTCPJ56.SGD","LU2602419157.SGD","IE00B3T34201.USD","LU1894683264.USD","LU1074936037.SGD","LU0345769128.USD","LU0345770308.USD","LU0965509101.SGD","LU1914381329.SGD","LU0122379950.USD","LU0823416689.USD","LU2129689514.USD","IE00BN8TJ469.HKD","LU2087621335.USD","SG9999015945.SGD","LU0234572021.USD","LU0683600562.USD","BK4599","LU0787776722.HKD","LU0345770993.USD","LU0266013472.USD","IE00B19Z3581.USD","LU0861579265.USD","LU1057294990.SGD","LU1721429741.USD","LU1674673428.USD","LU2347655156.SGD","SGXZ57979304.SGD","BK4533","SG9999015952.SGD","LU0795875086.SGD","LU0320765992.SGD","BK4534","LU2129689605.HKD","LU1883839398.USD","LU1061106388.HKD","LU1989763690.USD","LU0432979614.USD","LU0882574055.USD","LU1718418525.SGD","LU2750360641.GBP","LU2505996681.GBP","LU0070217475.USD","LU2471134796.USD","LU0225284248.USD","LU2237957811.SGD","LU0889566641.SGD","IE00BBT3K403.USD","LU1032955483.USD","SGXZ41872573.SGD","LU0965509283.SGD","LU0203347892.USD","LU1221951129.SGD","LU1066051498.USD","IE0009355771.USD","IE00BLSP4239.USD","IE00BZ1G4Q59.USD","IE0002141913.USD","LU0098860793.USD","LU1430594728.SGD","LU1839511570.USD","LU0689626769.HKD","SG9999015986.USD","LU2471134952.CNY","LU2471134879.HKD","LU0234570918.USD","LU0868494617.USD"],"gpt_icon":0},{"id":"2620623562","title":"E-Home Household Service Holdings Ltd. files initial beneficial ownership statement for Director Wong Heung Ming Henry","url":"https://stock-news.laohu8.com/highlight/detail?id=2620623562","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620623562?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:12","pubTimestamp":1773864721,"startTime":"0","endTime":"0","summary":"E-Home Household Service Holdings reported an initial statement of beneficial ownership on March 18, 2026. The filing lists Wong Heung Ming Henry Wong as a director of the company. The Form 3 stated that no securities are beneficially owned by Wong.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. E-Home Household Service Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLc4Qfjr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4192","EJH","BK4539"],"gpt_icon":0},{"id":"2620264720","title":"Virax Biolabs Group names director Evan Michael Norton in initial beneficial ownership filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2620264720","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620264720?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:08","pubTimestamp":1773864523,"startTime":"0","endTime":"0","summary":"Virax Biolabs reported an initial statement of beneficial ownership for director Evan Michael Norton. The filing listed stock options to buy 2,000 ordinary shares at USD 6 per share, expiring July 20, 2032. It also listed stock options for 10,000 ordinary shares at USD 6 per share, expiring April 18, 2033. Additional stock options covered 10,000 ordinary shares at USD 0.68 per share, expiring April 18, 2034. Another stock option grant covered 10,000 ordinary shares at USD 0.88 per share, expiring April 8, 2035.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Virax Biolabs Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL4w16j5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","VRAX","BK4175"],"gpt_icon":0},{"id":"2620264763","title":"Virax Biolabs Director Iain David Miller Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620264763","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620264763?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:07","pubTimestamp":1773864471,"startTime":"0","endTime":"0","summary":"Virax Biolabs reported an initial statement of beneficial ownership filed by Iain David Miller, a director. The filing listed no securities as beneficially owned by Miller. The date of the event requiring the statement was 03/18/2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Virax Biolabs Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL9JZGLS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRAX","BK4583","BK4175"],"gpt_icon":0},{"id":"2620252833","title":"Gilead Sciences Inc Stock (GILD) Moved Down by 3.37% on Mar 18: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620252833","media":"TradingKey","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620252833?lang=en_us&edition=fundamental","pubTime":"2026-03-18 22:15","pubTimestamp":1773843328,"startTime":"0","endTime":"0","summary":"• Gilead's 2026 Yeztugo sales forecast missed analyst expectations.\n• Gilead's 2026 EPS guidance fell at the lower end of analyst predictions.\n• Executives sold company shares, potentially pressuring the stock price.","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/Market-Movers/261694902-market-movers-gild-20260318","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360106947.USD","LU2361044865.SGD","SG9999015952.SGD","LU0882574139.USD","LU0323591593.USD","LU0456855351.SGD","LU1712237335.SGD","LLYZ","LU0672654240.SGD","LU1066051225.USD","LU1093756168.USD","LU1221951046.USD","LU1548497426.USD","LU2552382058.USD","IE0004445239.USD","IE00BSNM7G36.USD","SGXZ31699556.SGD","LU1059921491.USD","LU1145028129.USD","IE00B19Z3581.USD","LU2106854487.HKD","LU1066051811.HKD","LU2592432038.USD","LU0912757837.SGD","LU2746668461.USD","IE0004445015.USD","LU1983299246.USD","LU2471134879.HKD","LU2213496289.HKD","LU0787776722.HKD","LU2264538146.SGD","LU1244550494.USD","IE00B2B36J28.USD","LU0158827781.USD","LU2028103732.USD","LU2063271972.USD","LU2089283258.USD","LU1868836591.USD","LU2023250504.SGD","LU2168564149.EUR","LU2491050154.USD","LU0823416689.USD","LU1061106388.HKD","LU1280957306.USD","LU2087621335.USD","SGXZ51526630.SGD","BK4599","LU1551013425.SGD","IE00B3T34201.USD","IE00BGHQF631.EUR","SG9999013999.USD","LU2357305700.SGD","LU0203345920.USD","LU1366192091.USD","LU2089284900.SGD","LU0109394709.USD","LU0353189680.USD","LU1506573853.SGD","LU2471134796.USD","LU0683600562.USD","LU1674673691.USD","IE00BN29S564.USD","LU2089984988.USD","LU2361044949.HKD","LU0432979614.USD","LU0820561818.USD","LU2087625088.SGD","ELIL","LU2491049909.HKD","LLYX","LU1551013342.USD","LU2023250330.USD","LU0154236417.USD","LU1032955483.USD","LU2129689605.HKD","BK4588","LU2271345857.HKD","LU1935042991.SGD","LU1868836914.USD","LU0823434740.USD","IE0001KFT4U8.USD","IE00BLSP4239.USD","LU2237443622.USD","LU1868837136.USD","IE00BFTCPJ56.SGD","LU0256863811.USD","SG9999002224.SGD","IE00BZ1G4Q59.USD","LU1934455863.HKD","LU1127390331.HKD","LU1069344957.HKD","LU1732799900.SGD","LU0965509101.SGD","LU1623119135.USD","BK4592","BK7104","LU0792757196.USD","BK4581","LU1430594728.SGD","IE00BVYPNW00.USD","LU1066053197.SGD","LU0320765992.SGD","LU2456880835.USD","LU1720051017.SGD","LU0861579265.USD","LU0417517546.SGD","BK4550","LU2112291526.USD","IE00BFXG1179.USD","LU2462157665.USD","SGXZ57979304.SGD","LU2417539215.USD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","LU1929549753.HKD","IE00BVYPNV92.GBP","SGXZ99366536.SGD","LU1814569148.SGD","IE00BFSS8Q28.SGD","LU1093756325.SGD","LU0964807845.USD","IE00BJLML261.HKD","IE00BDGV0183.EUR","IE00B775H168.HKD","LU2468319806.SGD","SG9999018865.SGD","IE00BJT1NW94.SGD","SG9999001176.SGD","LU2430703095.HKD","LU0471298777.SGD","BK4516","IE00BK4W5M84.HKD","LU1914381329.SGD","IE00B1BXHZ80.USD","IE0002141913.USD","BK4566","IE00BJJMRX11.SGD","LU1496350502.SGD","LU1894683264.USD","IE00B4JS1V06.HKD","SG9999018857.SGD","BK4532","IE0009355771.USD","LU0795875086.SGD","LU2237438978.USD","LU1934455277.USD","LU1162221912.USD","LU0345770308.USD","LU2461242641.AUD","LU0094547139.USD","LU2168564222.USD","LU2756315318.SGD","LU1232071149.USD","IE0034235303.USD","LU0058720904.USD","LU0320765059.SGD","LU1074936037.SGD","IE00B1XK9C88.USD","LU2129689514.USD","IE00B4R5TH58.HKD","LU0096364046.USD","LU0234570918.USD","LU0965509010.AUD","LU0006306889.USD","LU0320765646.SGD","LU2896262040.SGD","LU1323610961.USD","LU1064131342.USD","LU0114720955.EUR","IE00BKPKM429.USD","LU2471134952.CNY","LU2756315664.SGD","LU0965509283.SGD","LU1974910355.USD","LU1291159041.SGD","IE00BJJMRZ35.SGD","LU0689472784.USD","LU1037948541.HKD","LU2505996681.GBP","SG9999001176.USD","LU2552382215.SGD","BK4578","LU2168563687.JPY","LU2237443895.HKD","LU0070217475.USD","LU0234572021.USD","LU1868837300.USD","LU1988902786.USD","LU1934455194.USD","BK4504","IE000M9KFDE8.USD","LU0466842654.USD","BK4585","LU2430703178.SGD","IE00B3PB1722.GBP","ELIS","GB00BDT5M118.USD","SG9999014898.SGD","LU1261432733.SGD","SGXZ81514606.USD","NVOX","SG9999015978.USD","LU0124676726.USD","LU0820562030.AUD","LU0471298694.HKD","SG9999001440.SGD","LU1244550221.USD","LU2237443978.SGD","LU1057294990.SGD","BK4533","LU0203202063.USD","SG9999014906.USD","LU1221951129.SGD","LU1718418525.SGD","LU0820561909.HKD","LU0385154629.USD","LU0210536198.USD","LU0689626769.HKD","SG9999017495.SGD","LU0823434583.USD","LU2602419157.SGD","LU1023059063.AUD","LU0316494557.USD","IE0002270589.USD","LU1244550577.SGD","BK4534","IE0005OL40V9.USD","LU2347655156.SGD","BK4583","LU0203201768.USD","LU0098860793.USD","LU1267930730.SGD","LU1778281490.HKD","LU1894683348.USD","LU2471134523.USD","IE00BKDWB100.SGD","LU1196500208.SGD","LU2552382132.HKD","LU1037948897.HKD","LU0238689110.USD","LU1732800096.USD","LU1839511570.USD","IE00BLSP4452.SGD","LU0889566641.SGD","IE00BWXC8680.SGD","LU0786609619.USD","LU2237443465.HKD","LU2129689431.USD","IE00BFSS7M15.SGD","LU0106261372.USD","LU0943347566.SGD","LU2746668974.SGD","SG9999002232.USD","LU1868836757.USD","LU0203347892.USD","LU0122379950.USD","LU1035775433.USD","BK4007","LU0345770993.USD","LU0345769128.USD","LU2237443549.SGD","LU1629891620.HKD","LU2023251221.USD","LU1989771016.USD","LU0158827948.USD","SG9999015945.SGD","LU2133065610.SGD","LU0354030438.USD","LU2750360641.GBP","IE00BJJMRY28.SGD","LU1804176565.USD","LU2111349929.HKD","LU2324357040.USD","LU0079474960.USD","LU0353189763.USD","LU0097036916.USD","GILD","SG9999014914.USD","LU2108987350.USD","LU0225283273.USD","NVOH","LU1720051108.HKD","LU0889565916.HKD","LU2168564065.EUR","LU0061475181.USD","LU0289739699.SGD","LU2168564495.EUR","IE00B19Z3B42.SGD","LU0985320562.USD","LU0256863902.USD","LU1585245621.USD","LU2361045086.USD","IE00BN8TJ469.HKD","IE00BBT3K403.USD","LU2430703251.USD","LU2505996509.AUD","LU0640476718.USD","LLII","LU0795875169.SGD","LU1267930813.SGD","BK4568","LU2265009873.SGD","IE00B42XCP33.USD","BK4139","LU2211815571.USD","LU1032466523.USD","LU0198837287.USD","BK4559","LU0965508806.USD","LU0266013472.USD","LU2750360997.AUD","IE00B7KXQ091.USD","LU0882574055.USD","LU1674673428.USD","LU1066051498.USD","LU1571399168.USD","LU2237443382.USD","LU2236285917.USD","LU2491050071.SGD","LU0354030511.USD","LU0109391861.USD","IE00BK4W5L77.USD","LU0345769631.USD","LU0708995401.HKD","SG9999014880.SGD","SG9999015986.USD","LU1917777945.USD"],"gpt_icon":0},{"id":"2620523489","title":"Compugen Ltd. director Gilead Halevy files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620523489","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620523489?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:07","pubTimestamp":1773828459,"startTime":"0","endTime":"0","summary":"Gilead Halevy filed an initial statement of beneficial ownership for Compugen in connection with his role as a director. The filing reported direct ownership of 11,407 ordinary shares. It also listed share options to buy 35,000 ordinary shares at a price of USD 3.85.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compugen Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL8cncQv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU0965509010.AUD","BK4550","BK4588","LU0889565916.HKD","BK4578","LU1571399168.USD","LU2324357040.USD","LU0289739699.SGD","BK4568","LU0109394709.USD","LU1037948897.HKD","BK4121","LU1037948541.HKD","LU2087621335.USD","LU1023059063.AUD","LU1061106388.HKD","CGEN","BK4139","IE0002270589.USD","LU0823416689.USD","LU0861579265.USD","SG9999015986.USD","LU1057294990.SGD","IE00B3T34201.USD","LU1778281490.HKD","LU0882574055.USD","LU0114720955.EUR","BK4532","LU1674673691.USD","LU0320765992.SGD","LU1934455194.USD","LU0965509101.SGD","SG9999015945.SGD","IE00B19Z3581.USD","BK4585","LU0122379950.USD","LU0965509283.SGD","BK4583","LU1934455863.HKD","BK4566","GILD","IE00B7SZLL34.SGD","LU1934455277.USD","LU0234570918.USD","SG9999015978.USD","LU0058720904.USD","LU1839511570.USD","LU0965508806.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2620231724","title":"Tonix Pharmaceuticals replaces EisnerAmper with PwC as independent auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2620231724","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620231724?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:04","pubTimestamp":1773828255,"startTime":"0","endTime":"0","summary":"Tonix dismissed EisnerAmper as its independent registered public accounting firm on March 16, 2026. The audit committee approved the change, and Tonix said the dismissal was not related to disagreements on accounting principles, financial statement disclosure, or auditing scope. EisnerAmper’s audit reports for fiscal 2025 and 2024 included a going-concern explanatory paragraph tied to continuing losses and negative operating cash flows. Tonix appointed PwC as its new independent registered public accounting firm for fiscal 2026 and related interim periods on March 16, 2026. Tonix said it had not consulted with PwC on accounting or audit opinion matters during fiscal 2025, fiscal 2024, or the interim period through the engagement date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL6576pR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNXP","BK4139","BK4583"],"gpt_icon":0},{"id":"2620497409","title":"Gilead Chief Comm & Corp Aff Officer Johanna Mercier disposes of USD 432,690 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620497409","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620497409?lang=en_us&edition=fundamental","pubTime":"2026-03-18 06:56","pubTimestamp":1773788219,"startTime":"0","endTime":"0","summary":"Johanna Mercier, Chief Communications and Corporate Affairs Officer at Gilead Sciences, reported a disposal of 3,000 common shares. The shares were sold at USD 144.23 each.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL9Bmkr0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU1066051498.USD","LU0861579265.USD","IE00BKVL7J92.USD","LU1674673428.USD","SG9999015986.USD","BK4583","LU1934455194.USD","IE00B3T34201.USD","LU1037948541.HKD","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0109394709.USD","BK4578","LU0320765992.SGD","BK4585","LU1037948897.HKD","LU2087621335.USD","SG9999015952.SGD","LU1061106388.HKD","BK4568","LU1934455863.HKD","LU1778281490.HKD","LU0965509010.AUD","LU1585245621.USD","BK4588","LU1839511570.USD","LU0122379950.USD","LU0058720904.USD","LU1066053197.SGD","LU0889565916.HKD","LU2112291526.USD","IE00B19Z3581.USD","LU1934455277.USD","IE00B7SZLL34.SGD","LU0234570918.USD","GILD","BK4139","IE00BSNM7G36.USD","BK4566","LU0289739699.SGD","LU0882574055.USD","LU0965509283.SGD","SG9999015945.SGD","IE00B19Z3B42.SGD","LU0965508806.USD","LU1430594728.SGD","LU2324357040.USD","BK4532","LU2468319806.SGD"],"gpt_icon":0},{"id":"2620288406","title":"Gilead CFO Andrew D. Dickinson disposes of USD 432,690 of common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620288406","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620288406?lang=en_us&edition=fundamental","pubTime":"2026-03-18 06:14","pubTimestamp":1773785665,"startTime":"0","endTime":"0","summary":"Andrew Dickinson, Chief Financial Officer of Gilead Sciences, reported a disposal of 3,000 common shares. The shares were sold at USD 144.23 each.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL14FjWz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead CFO Andrew D. Dickinson disposes of USD 432,690 of common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU2089984988.USD","LU0122379950.USD","LU1066051498.USD","LU2324357040.USD","LU1066053197.SGD","BK4566","LU0320765992.SGD","BK4139","LU0823416689.USD","LU0114720955.EUR","LU1023059063.AUD","IE00B19Z3581.USD","IE0002270589.USD","BK4532","SG9999015978.USD","LU0861579265.USD","LU2087621335.USD","LU1674673691.USD","LU1037948897.HKD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU1585245621.USD","BK4583","BK4585","LU1057294990.SGD","LU0965509101.SGD","LU1037948541.HKD","IE00B3T34201.USD","LU0234570918.USD","LU0965509283.SGD","IE00BZ1G4Q59.USD","LU1674673428.USD","LU1934455863.HKD","LU2468319806.SGD","LU2112291526.USD","LU0109394709.USD","LU1934455194.USD","LU1778281490.HKD","GILD","SG9999015945.SGD","LU1571399168.USD","BK4588","LU1430594728.SGD","SG9999015952.SGD","BK4578","LU0965509010.AUD","LU1061106388.HKD","LU0289739699.SGD","SG9999015986.USD"],"gpt_icon":0},{"id":"2620403525","title":"Tonix Pharmaceuticals to present oral and two poster sessions at AACR Annual Meeting 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620403525","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620403525?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:35","pubTimestamp":1773779740,"startTime":"0","endTime":"0","summary":"Tonix will present one oral session and two posters at the AACR Annual Meeting 2026 in San Diego on April 17-22, 2026. An oral presentation titled “TFF2 deficiency amplifies IL-1β-driven inflammation and promotes aging-associated gastric tumor progression” is scheduled for April 21, 2026, 2:30-4:30 p.m. PT. Two posters are scheduled for April 21, 2026, 2:00-5:00 p.m. PT and April 22, 2026, 9:00 a.m.-12:00 p.m. PT.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL9sxpWm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","IE00BGHQF748.EUR","LU2095319765.USD","IE00BKPKM429.USD","LU2210149790.SGD","BK4112","LU2210150020.SGD","LU0314104364.USD","SG9999014013.SGD","BK4588","SG9999014005.SGD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","TNXP","BK4139","BK4585","IE00B64PRP62.GBP","SG9999014021.USD","IE00BN0W2T93.GBP","SG9999014039.USD","NDAQ"],"gpt_icon":0},{"id":"2620403594","title":"Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-Oncology Portfolio at the American Association for Cancer Research (Aacr) Annual Meeting 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620403594","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620403594?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:35","pubTimestamp":1773779700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nTUA2DGTFN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","BK4139","TNXP"],"gpt_icon":0},{"id":"2620470649","title":"Health Rounds: Blood test improves detection of endometriosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2620470649","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620470649?lang=en_us&edition=fundamental","pubTime":"2026-03-18 03:31","pubTimestamp":1773775865,"startTime":"0","endTime":"0","summary":"Health Rounds: Blood test improves detection of endometriosis Health Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us?Forward this newsletter to them. They can also subscribe hereBy Nancy LapidMarch 17  - Hello Health Rounds readers!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nL1N4050X2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","BK4585","VTRS","BK4139","BK4588","LU1839511570.USD","NRSN","BK4583","BK4007"],"gpt_icon":0},{"id":"2620604471","title":"Mpox Is on the Rise in the U.S. 3 Vaccine Stocks Worth a Second Look. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2620604471","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620604471?lang=en_us&edition=fundamental","pubTime":"2026-03-18 00:49","pubTimestamp":1773766140,"startTime":"0","endTime":"0","summary":"New York City officials have confirmed the first case of a more severe strain case of mpox. While the risk of transmission remains low, shares of certain vaccine-makers might be worth a second look.Mpox, formerly known as monkeypox, is a viral infection characterized by a flu-like fever and rash that can last weeks. It's caused by a virus in the same family as smallpox, though it's less contagious and less severe.Bavarian Nordic is the biggest player to keep an eye on. With a market capitalization of just over $2 billion and shares that trade over the counter in the U.S., the name might not be widely known to investors outside the biotechnology space.The company manufactures one of only two approved mpox vaccines in the U.S. Because mpox is a viral infection, the answer isn't as simple as taking antibiotics to treat it. However, as is the case with Covid, people can vaccinate to build their body's natural resistance to it.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SIGA","BK4583","BK4007","BK4139","EBS"],"gpt_icon":0},{"id":"2620478238","title":"Aethlon Medical Completes Pre-Funded Warrant Exercises, Simplifying Equity","url":"https://stock-news.laohu8.com/highlight/detail?id=2620478238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620478238?lang=en_us&edition=fundamental","pubTime":"2026-03-17 21:52","pubTimestamp":1773755549,"startTime":"0","endTime":"0","summary":"An update from Aethlon Medical ( ($AEMD) ) is now available. Aethlon Medical, Inc., a medical technology company, reported that it has 1,569,110 sh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-completes-pre-funded-warrant-exercises-simplifying-equity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aethlon-medical-completes-pre-funded-warrant-exercises-simplifying-equity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AEMD","BK4588","BK4568","EQR","BK4583","BK4082","BK4215","BK4585"],"gpt_icon":0},{"id":"2620420879","title":"Aethlon Medical says all pre-funded warrants have been exercised","url":"https://stock-news.laohu8.com/highlight/detail?id=2620420879","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620420879?lang=en_us&edition=fundamental","pubTime":"2026-03-17 21:15","pubTimestamp":1773753346,"startTime":"0","endTime":"0","summary":"Aethlon Medical said recent exercises of certain pre-funded warrants increased its common shares outstanding to 1,569,110 as of the close of business on March 16, 2026. The company said all previously outstanding pre-funded warrants have been exercised.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aethlon Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 17, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDLbP7NTf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD","BK4583","BK4082","BK4568"],"gpt_icon":0},{"id":"2620926534","title":"Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2620926534","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620926534?lang=en_us&edition=fundamental","pubTime":"2026-03-17 05:27","pubTimestamp":1773696420,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  slid 1.81% to $1.63 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 1.22% to 22,374.18 and the Dow Jones Industrial Average  rising 0.83% to 46,946.41.This was the stock's fourth consecutive day of losses.Inovio Pharmaceuticals Inc. closed 45.28% below its 52-week high of $2.98, which the company achieved on September 9th.The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson  rose 0.69% to $243.19, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  rose 0.11% to $26.61.Trading volume  remained 334,893 below its 50-day average volume of 1.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 16, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published indepe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU0234572021.USD","LU0122379950.USD","LU0058720904.USD","LU0787776722.HKD","LU0985481810.HKD","SG9999003800.SGD","LU1221951046.USD","LU2471134879.HKD","LU0912757837.SGD","LU2129689514.USD","LU2468319806.SGD","IE00BZ1G4Q59.USD","LU1585245621.USD","IE00B19Z3581.USD","LU0114720955.EUR","IE00BLSP4452.SGD","IE00B3T34201.USD","LU0203347892.USD","IE00B1BXHZ80.USD","LU0321505868.SGD","IE000M9KFDE8.USD","LU0306807586.USD","IE00BGHQF631.EUR","LU0070217475.USD","LU0689626769.HKD","LU0225771236.USD","LU1894683348.USD","LU0889566641.SGD","LU2430703251.USD","LU1935042991.SGD","LU1732799900.SGD","LU2471134523.USD","BK4599","LU0321505439.SGD","IE00B7SZLL34.SGD","LU0345770308.USD","SG9999001440.SGD","LU0345769128.USD","LU2089984988.USD","LU1983299246.USD","IE00BBT3K403.USD","IE0034235303.USD","LU1929549753.HKD","IE00BJT1NW94.SGD","BK4581","LU0225284248.USD","IE00BJJMRZ35.SGD","LU0345769631.USD","IE00BVYPNV92.GBP","BK4007","SG9999013999.USD","SGXZ57979304.SGD","LU2602419157.SGD","IE00BKVL7J92.USD","IE00BLSP4239.USD","LU0640476718.USD","LU2750360997.AUD","LU0882574055.USD","LU1261432733.SGD","LU0234570918.USD","LU2112291526.USD","LU1883839398.USD","BK4139","LU0203345920.USD","LU1267930813.SGD","LU2133065610.SGD","LU1196500208.SGD","LU0124676726.USD","LU1061106388.HKD","LU1674673428.USD","LU1074936037.SGD","LU2471134796.USD","SG9999011175.SGD","LU2129689431.USD","LU1506573853.SGD","IE00BDGV0183.EUR","LU1023059063.AUD","BK4534","SG9999002232.USD","BK4559","LU1430594728.SGD","LU0320765646.SGD","LU0683600562.USD","BK4588","SG9999001176.SGD","LU0345770993.USD","LU1244550221.USD","LU1732800096.USD","LU0985320562.USD","LU1059921491.USD","IE0002141913.USD","LU0795875086.SGD","IE00B42XCP33.USD","LU0868494617.USD","LU1066053197.SGD","LU1162221912.USD","IE00BSNM7G36.USD","LU1496350502.SGD","LU1778281490.HKD","LU1066051811.HKD","BK4583","BK4532","IE00BVYPNW00.USD","LU2592432038.USD","LU1718418525.SGD","LU2471134952.CNY","LU2347655156.SGD","BK4592","BK4568","LU1221951129.SGD","BK4550","LU0795875169.SGD","LU2505996509.AUD","IE00BFXG1179.USD","LU1066051498.USD","IE00BFTCPJ56.SGD","IE0001KFT4U8.USD","LU1674673691.USD","LU1066051225.USD","IE00B3PB1722.GBP","LU0466842654.USD","SG9999002224.SGD","LU1032466523.USD","LU2129689605.HKD","LU0098860793.USD","IE00B2B36J28.USD","LU0792757196.USD","LU0456855351.SGD","LU0289739699.SGD","LU1032955483.USD","LU2750360641.GBP","LU1244550577.SGD","LU1914381329.SGD","IE0009355771.USD","SG9999001176.USD","IE00B19Z3B42.SGD","LU0432979614.USD","LU1894683264.USD","LU2430703178.SGD","INO","LU2430703095.HKD","LU0170899867.USD","LU1280957306.USD","LU1244550494.USD","IE0002270589.USD","BK4585","IE00BN8TJ469.HKD","LU0306806265.USD","LU1057294990.SGD","BK4533","LU2505996681.GBP","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2620496048","title":"Inovio Pharmaceuticals CEO and CFO face securities class action as control person defendants","url":"https://stock-news.laohu8.com/highlight/detail?id=2620496048","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620496048?lang=en_us&edition=fundamental","pubTime":"2026-03-17 04:00","pubTimestamp":1773691248,"startTime":"0","endTime":"0","summary":"A securities class action has been filed against Inovio, naming CEO Jacqueline E. Shea and CFO Peter Kies as individual defendants under a control person theory. The complaint alleges the executives had authority over the company’s SEC filings, press releases, and other public communications. It also alleges they signed Sarbanes-Oxley certifications attached to quarterly and annual reports. The filing deadline to seek appointment as lead plaintiff is April 7, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL19pHnL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014021.USD","IE00BN0W2W23.USD","LU2095319765.USD","IE00BN0W2V16.EUR","INO","SG9999014039.USD","BK4585","BK4588","LU2210150020.SGD","BK4139","IE00BKPKM429.USD","LU2210149790.SGD","BK4568","LU0314104364.USD","SG9999014005.SGD","NDAQ","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","SG9999014013.SGD","BK4583","IE00B64PRP62.GBP","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"1179297055","title":"Intel's Xeon 6 Selected as Primary CPU for NVIDIA's DGX Rubin System, Boosting Stock by 3.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1179297055","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179297055?lang=en_us&edition=fundamental","pubTime":"2026-03-17 03:36","pubTimestamp":1773689812,"startTime":"0","endTime":"0","summary":"At the 2026 NVIDIA GTC conference, Intel announced that its Xeon 6 processor has been chosen as the main CPU for NVIDIA's DGX Rubin NVL8 system. The company stated that this development highlights...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550577.SGD","LU2111349929.HKD","LU1116320901.HKD","LU2360032135.SGD","LU2505996509.AUD","LU0320765059.SGD","LU0267386448.USD","LU0353189680.USD","BK4612","LU2361045086.USD","LU1202635105.USD","LU0109392836.USD","LU0345768153.USD","LU0943347566.SGD","LU2491050071.SGD","NVDG","SG9999014898.SGD","LU2237957811.SGD","SG9999001424.SGD","IE00BWXC8680.SGD","LU2473716301.USD","LU0390134368.USD","LU0124676726.USD","IE00BMPRXN33.USD","SG9999015341.SGD","BK4602","LU1935042215.USD","LINT","IE0001KFT4U8.USD","LU0861579265.USD","LU1720051017.SGD","HK0000320223.HKD","LU0979878070.USD","BK4534","IE000M9KFDE8.USD","LU0256863811.USD","IE0004086264.USD","LU1854104046.USD","NVIW.SI","BK4598","BK4551","LU2931357623.SGD","LU1989764748.USD","LU0640476718.USD","LU2543165471.USD","NVDD","LU1571399168.USD","LU0823417653.USD","IE000KEQY171.SGD","LU1066051498.USD","SG9999000418.SGD","IE00BJTD4N35.SGD","IE00BQXX3F31.USD","IE00B5949003.HKD","LU0210528500.USD","LU2148611432.USD","LU2290526834.HKD","NVDS.UK","SG9999014575.USD","SG9999002232.USD","LU2456880835.USD","LU1923622291.USD","LU1934455194.USD","IE00BQXX3D17.EUR","LU0823421416.USD","LU1803068979.SGD","LU2361044949.HKD","LU0689626769.HKD","SGXZ31699556.SGD","LU0889565833.HKD","NVII","LU0069063385.USD","LU1674673691.USD","LU0823434740.USD","LU1066051811.HKD","LU0170899867.USD","LU1645745479.HKD","LU1983260115.SGD","LU2125909247.SGD","LU2430703251.USD","LU2462157665.USD","LU2065171402.SGD","IE0009356076.USD","NVDX","LU2413666699.HKD","LU1815336760.USD","LU0211327993.USD","IE0034235188.USD","LU0225283273.USD","IE00BHPRN162.USD","LU0965509010.AUD","BK4614","LU1691799644.USD","IE00BDCRKT87.USD","BK4533","SG9999014906.USD","LU1868837136.USD","BK4527","LU1127390331.HKD","LU2430703095.HKD","LU1116320737.USD","LU1854103824.USD","LU1712237335.SGD","LU2237957902.USD","LU1917777945.USD","LU2487616109.SGD","LU1119994496.HKD","INTW","NVDU","LU0345770308.USD","LU2491050154.USD","LU2023251221.USD","NVDW","HK0000320264.USD","LU0342679015.USD","SG9999018857.SGD","LU0048584097.USD","SG9999018865.SGD","BK4575","LU1974910355.USD","LU0321505439.SGD","LU0672654240.SGD","LU1821325948.USD","LU2097344357.USD","IE00BKVL7J92.USD","LU1435385759.SGD","SG9999015952.SGD","LU0203201768.USD","LU2506951875.HKD","LU0719512351.SGD","LU0964807845.USD","LU2860962120.EUR","IE0005OL40V9.USD","LU2552382215.SGD","IE00BJLML261.HKD","LU0128525929.USD","LU1153585028.USD","LU1429558221.USD","LU1066051225.USD","LU1064131342.USD","IE0009G5SDU7.USD","LU2089284900.SGD","LU0203202063.USD","LU0061474705.USD","BK4543","IE00BJTD4V19.USD","LU0708995401.HKD","LU1934455863.HKD","LU2242649171.HKD","LU0882574139.USD","LU0011850046.USD","LU2326559502.SGD","LU1914381329.SGD","LU2063271972.USD","IE00BYXW3230.USD","LU0316494557.USD","IE00BN29S564.USD","LU2265009873.SGD","IE00B3SWFQ91.USD","SGXZ99366536.SGD","LU2087625088.SGD","LU1242518931.SGD","LU0985320562.USD","LU1400636657.SGD","IE00BD6J9T35.USD","LU2097344431.USD","SG9999014567.USD","IE0003U64NQ7.SGD","LU0787776722.HKD","LU0082616367.USD","LU0472753341.HKD","LU1861215975.USD","BK4532","LU1935042991.SGD","LU0511384066.AUD","LU0061474960.USD","LU0345769128.USD","LU1935043536.SGD","LU2420271590.USD","IE00B19Z9505.USD","LU0354030438.USD","LU2125909759.SGD","LU2361044865.SGD","LU1496350171.SGD","LU2272731782.SGD","LU0708994859.HKD","LU0210536198.USD","LU0266013472.USD","LU1839511570.USD","LU2168564065.EUR","LU1242518857.USD","LU2360106780.USD","LU1261432733.SGD","LU0234572021.USD","LU2065170008.USD","BK4512","LU1861127337.USD","SG9999015986.USD","LU0157215616.USD","LU0528227936.USD","LU1670756490.USD","LU1868836914.USD","LU1861220033.SGD","SG9999015978.USD","LU2506952170.USD","LU2552382058.USD","LU1642822529.SGD","LU2322448791.USD","LU0274383776.USD","LU0079474960.USD","LU2461242641.AUD","BK4581","LU1989772840.SGD","LU2506952097.USD","LU1992135399.USD","LU1267930730.SGD","LU0345768740.USD","LU0347712357.USD","IE00BKDWB100.SGD","LU0642271901.SGD","LU0323591593.USD","LU2458330243.SGD","LU2750360641.GBP","LU0175139822.USD","LU0072462426.USD","LU2023250504.SGD","BK4529","BK4535","LU2322448957.HKD","04335","BK4554","BK4550","IE0004445239.USD","LU2294711713.HKD","LU0215105999.USD","LU0957791311.USD","LU0444971666.USD","LU2357305700.SGD","LU2471134952.CNY","IE00BQXX3C00.GBP","LU1992135472.HKD","LU1035775433.USD","LU1852331112.SGD","LU2087621335.USD","NVD3.UK","LU0494093205.USD","SG9999014559.SGD","LU2237438978.USD","LU1400636491.USD","LU0276348264.USD","LU0965509101.SGD","LU1232071149.USD","IE00BFSS8Q28.SGD","LU1951198990.SGD","LU0823414478.USD","LU2168564495.EUR","IE00B3S45H60.SGD","LU0823421333.USD","LU1814569148.SGD","LU2065171311.SGD","LU0127658192.USD","SG9999015358.SGD","LU0154236417.USD","LU0265550359.USD","LU1791710400.SGD","LU1066053197.SGD","BK4585","LU0965509283.SGD","LU0786609619.USD","IE00B775SV38.USD","LU1551013425.SGD","LU2054465674.USD","LU1720051108.HKD","LU0251132253.USD","LU0868494708.USD","LU1923623000.USD","NVDY","LU2065169927.USD","LU2089283258.USD","IE00B19Z8X17.USD","IE00BKPKM429.USD","LU2125154935.USD","HK0000914686.HKD","LU0211328371.USD","LU0950375773.USD","LU2471134796.USD","LU0476273544.USD","2NVD.UK","IE00BZ1G4Q59.USD","LU2092937148.SGD","NVDL","LU2491049909.HKD","IE00B7KXQ091.USD","LU1934455277.USD","LU1951200564.SGD","LU0823417737.USD","LU2244417387.USD","IE0034235303.USD","LU0053666078.USD","LU0210533765.USD","LU2272731865.HKD","IE00B1XK9C88.USD","LU0265550946.USD","LU2413666426.HKD","LU1069344957.HKD","NVD","LU0289739343.SGD","LU0234570918.USD","BK4583","LU1244550494.USD","IE00B4YYXB79.USD","LU2168564149.EUR","LU2756315318.SGD","NVDA","LU2286300806.USD","SG9999014542.SGD","LU1868836591.USD","LU1989772923.USD","BK4579","LU1366192091.USD","LU0823414551.USD","LU2083900584.USD","LU1145028129.USD","LU0107464264.USD","LU0077335932.USD","LU2249611893.SGD","ANV","BK4503","LU0096364046.USD","LU1935043023.USD","LU2247934214.USD","LU0444973449.USD","SG9999014914.USD","LU2471134879.HKD","SG9999017495.SGD","LU0354030511.USD","LU0057025933.USD","LU2506951792.HKD","SG9999004303.SGD","LU0683600562.USD","LU1815333072.USD","LU0310800379.SGD","LU1778281490.HKD","LU0080751232.USD","LU0109391861.USD","LU1988902786.USD","LU0353189763.USD","LU0097036916.USD","LU2028103732.USD","SGXZ23171101.USD","LU1037948897.HKD","LU0289960550.SGD","LU2430703178.SGD","LU0957808578.USD","NVDQ","LU0256863902.USD","LU2592432038.USD","LU1868836757.USD","IE0004445015.USD","LU2271345857.HKD","LU0466842654.USD","LU1267930573.SGD","LU0820561818.USD","LU0321505868.SGD","LU1923622614.USD","LU1804176565.USD","LU1989764664.SGD","LU1699723380.USD","LU0345769631.USD","LU1400636574.HKD","LU0056508442.USD","LU1935042488.USD","LU2168564222.USD","BK4592","LU2250418816.HKD","LU1791710582.SGD","BK4605","LU1316542783.SGD","LU2125154778.USD","LU2458330169.SGD","LU2108987350.USD","BK4608","LU1623119135.USD","LU2403377893.USD","IE00BFSS7M15.SGD","LU1366333091.USD","LU0823434583.USD","LU1037948541.HKD","LU0094547139.USD","LU2213496289.HKD","LU2125909916.SGD","INTC","IE000W1ABFV2.USD","LU0158827948.USD","SG9999015945.SGD","LU2168563687.JPY","SG9999014880.SGD","HK0000306685.HKD","LU2471134523.USD","IE000YTNTUN2.SGD","LU1629891620.HKD","BK4515","LU0689472784.USD","LU0348723411.USD","LU1496350502.SGD","LU1551013342.USD","3NVD.UK","IE00BK4W5L77.USD","IE00BK4W5M84.HKD","LU2242650005.HKD","LU0942090050.USD","LU2089985449.USD","IE00BJJMRY28.SGD","LU0965508806.USD","IE0004091025.USD","BK4588","LU1323610961.USD","LU0158827781.USD","LU2433249047.HKD","LU0308772762.SGD","LU0417517546.SGD","LU0557290698.USD","LU2552382132.HKD","LU1721428933.USD","LU2746668974.SGD","IE00BZ199S13.USD","LU0006306889.USD","BK4567","LU2106854487.HKD","LU2463028550.USD","NVDS","SGXZ81514606.USD","LU1084165304.USD","LU2357125470.USD","BK4549","LU2191332357.HKD","NVD2.UK","LU2896262040.SGD","LU0061475181.USD","IE00BDRTCR15.USD","LU0820562030.AUD","LU2272731600.USD","LU0345770993.USD","LU0820561909.HKD","LU0106261372.USD","BK4587","IE0034235295.USD","LU2077746001.SGD","LU2360107168.USD","LU2211815571.USD","SGXZ51526630.SGD","LU2756315664.SGD","LU2381873111.SGD","LU0868494617.USD","LU0070217475.USD","LU2746668461.USD","IE00B775H168.HKD","BK4141","IE00BMPRXQ63.HKD","LU2092627202.USD","LU0081259029.USD","NVDB","IE000ITXATA3.USD","SG9999002224.SGD","IE00B1BXHZ80.USD","LU0238689110.USD","BK4196","LU2505996681.GBP","DIPS","IE00B3M56506.USD","SNVD.UK","IE00BMPRXR70.SGD","LU2602419157.SGD","LU1718418525.SGD","LU1244550221.USD","BK4548","LU0289961442.SGD","HK0000914660.USD","IE00B19Z8W00.USD","IE00B4JS1V06.HKD","GB00BDT5M118.USD","LU1280957306.USD","LU2417539215.USD","LU0788109477.HKD","LU2452424414.USD","IE00BJJMRX11.SGD","LU0096362180.USD","LU1868837300.USD","LU2750360997.AUD","LU1674673428.USD","LU0187121727.USD","LU0310799852.SGD","LU0724617625.USD","LU1267930490.SGD","HK0000306701.USD","LU2264538146.SGD","LU2236285917.USD","LU2506951958.HKD","LU1633808545.USD","LU0029864427.USD","LU1548497426.USD","LU2023250330.USD","LU2125909593.SGD","LU0198837287.USD"],"gpt_icon":1},{"id":"2619595450","title":"Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO) and Tonix Pharma (TNXP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619595450","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619595450?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:30","pubTimestamp":1773660640,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Jade Biosciences (JBIO – Research Report) and Tonix ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-jade-biosciences-jbio-and-tonix-pharma-tnxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-jade-biosciences-jbio-and-tonix-pharma-tnxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4583","BK4585","LU0029874061.USD","TNXP","BK4588","XLV","LABU","BK4539","BK4137","JBIO","HCSG","XBI","BK4581","BK4139"],"gpt_icon":0},{"id":"2619814596","title":"Tonix Pharmaceuticals Holding Corp. publishes investor presentation on TONMYA fibromyalgia launch and USD 208 million cash position","url":"https://stock-news.laohu8.com/highlight/detail?id=2619814596","media":"Reuters","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619814596?lang=en_us&edition=fundamental","pubTime":"2026-03-14 06:08","pubTimestamp":1773439691,"startTime":"0","endTime":"0","summary":"Tonix Pharmaceuticals Holding Corp. publishes investor presentation on TONMYA fibromyalgia launch and USD 208 million cash position. Tonix said its investor deck highlights three FDA-approved products and a focus on CNS, infectious disease and immunology. The company reported about USD 208 million in cash as of Dec. 31, 2025, and said it has no debt. Tonix said TONMYA, a sublingual cyclobenzaprine formulation for fibromyalgia, generated USD 1.4 million in net sales for Nov. 17 to Dec. 31, 2025. The deck said that from Nov. 17, 2025 through Feb. 27, 2026, more than 1,500 prescribers wrote TONMYA prescriptions and about 2,500 patients initiated treatment. Tonix listed WAC prices for TONMYA at USD 1,860 for a 60-count prescription and USD 930 for a 30-count prescription.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpos","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL8NRcwj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNXP","BK4583","BK4139"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0161},{"period":"3month","weight":-0.0009},{"period":"6month","weight":0.0129},{"period":"1year","weight":0.1827},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4583","nameEN":"BK4583"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Monkeypox Concept,BK4583,Monkeypox Concept股票,Monkeypox Concept股票老虎,Monkeypox Concept股票老虎国际,Monkeypox Concept行情,Monkeypox Concept股票行情,Monkeypox Concept股价,Monkeypox Concept股市,Monkeypox Concept股票价格,Monkeypox Concept股票交易,Monkeypox Concept股票购买,Monkeypox Concept股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction